December 2013 FDA Recall Propofol by Hospira Inc.
D-1033-2014 - Presence of Particulate Matter

This Class II drug recall was voluntarily initiated by Hospira Inc. on December 12, 2013 for the product Propofol. The FDA reported the reason for recall as presence of particulate matter. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1033-2014

Reason for Recall
Presence of Particulate Matter: Glass defect located on the interior neck of the vial identified glass surface abrasions and visible embedded particulate matter which could result in the potential for small glass flakes or embedded metal particulate to become dislodged into the solution.
Initiated
12-12-2013
Reported
01-29-2014
Quantity
126,425 vials

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Propofol Injectible Emulsion, 1%, 200 mg/20 mL (10 mg/mL), 20 mL Single patient infusion vial, packaged in 5 Units x 20 mL per carton, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-4699-30.

Batch or Lot Expiration Information

Lot# : 27-568-DJ*, Exp 03/15, Note * may be followed by 01